Streetbeat News

Products Services

VUZI

Vuzix has been selected by AFWERX for a SBIR Phase I contract to develop augmented reality head-mounted displays using waveguide technologies to address challenges faced by the Department of the Air Force.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:31 pm

PGEN

Precigen announced that its Phase 1/2 study for PRGN-2012 in treating Recurrent Respiratory Papillomatosis (RRP) met primary safety and efficacy endpoints. The study showed significant reductions in surgical interventions and durable complete responses in patients. PRGN-2012 was well-tolerated and induced strong immunological responses. A rolling BLA submission is anticipated in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:31 pm

SERV

Serve Robotics (NASDAQ:SERV) has announced the deployment of DriveU.auto's connectivity platform to enhance the performance of its autonomous delivery robots. This move supports Serve's goal to deploy up to 2,000 robots on the Uber Eats platform.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:25 pm

ACN

AIBU

IETC

Accenture (NYSE:ACN) has partnered with Kraken Technologies to accelerate EDF's UK retail business's digital transformation. The collaboration aims to enhance the adoption of smart energy products through an AI-enabled platform. Accenture's senior managing director highlighted the importance of modernizing the digital core for utilities. Additionally, Accenture Song was recently appointed as the global creative and content agency for Randstad NV (OTC:RANJY). Investors can gain exposure to Accenture through ETFs like IETC and AIBU. ACN shares are slightly down premarket.

Portfolio Pulse from Lekha Gupta

June 03, 2024 | 1:24 pm

GH

Guardant Health and Washington University will present a study at the 2024 ASCO meeting highlighting the utility of ctDNA to address racial inequities in the use of targeted therapies and clinical trial enrollment. The study, using the Guardant360® blood test, found that Black patients with PIK3CA mutations in advanced breast cancer were less likely to be enrolled in clinical trials and receive targeted therapy compared to White patients.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:22 pm

OCUL

Ocular Therapeutix has announced a strategic reduction in its workforce, eliminating 37 employees, or 13% of its total workforce. This move is aimed at focusing resources on the clinical development of AXPAXLI for wet age-related macular degeneration.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:20 pm

NUE

Nucor Corporation (NYSE:NUE) has announced the acquisition of Rytec Corporation, a leading manufacturer of high-performance commercial doors, for $565 million in cash. The deal is valued at approximately 12.5x Rytec's estimated 2024 EBITDA.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:19 pm

TASK

TaskUs, Inc. (NASDAQ:TASK) and Mavenoid have announced a strategic partnership to enhance AI-powered product support solutions. This collaboration aims to optimize personalized self-help product support for leading consumer brands.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:17 pm

ABT

CVKD

Cadrenal Therapeutics presented new trial data at the ISHLT Conference, highlighting the importance of anticoagulation quality in LVAD patients. The ARIES-HM3 Clinical Study, sponsored by Abbott, showed that tecarfarin, which recently received Orphan Drug Designation from the FDA, has the potential to improve patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:16 pm

NTGR

An ITC judge has ruled that TP-Link violated U.S. trade laws by infringing on NETGEAR's patents through the import and sale of multi-band Wi-Fi devices, routers, and mesh networking devices in the U.S.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 1:15 pm